Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 2/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2238005 | 0.92 | PAOX (0.59) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL540786 | 0.91 | PAOX (0.62) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL721355 | 0.90 | PAOX (0.64) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL20966331 | 0.89 | PAOX (0.65) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL169004 | 0.89 | PAOX (0.65) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL13520192 | 0.88 | TSHR (0.49) | PAOXHPGDDUSP3ALDH1A1CYP2D6 | |
| Hydrochloric Acid SCHEMBL2488967 | 0.88 | PAOX (0.62) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL22317835 | 0.87 | PAOX (0.58) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL76577 | 0.86 | PAOX (0.57) | PAOXHPGDDUSP3ALDH1A1CYP2C19 | |
| SCHEMBL13822725 | 0.86 | ACE2 (0.48) | PAOXALDH1A1SMN1; SMN2USP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751380-A | Polyamine heterocyclic compound, preparation method and application thereof, and polyamine heterocyclic compound combined solution | 大连理工大学 | 2025-04-04 | — | — | CN | disclosed |
| EP-2121771-B2 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2016-12-07 | — | — | EP | disclosed |
| EP-3099691-A1 | PRO-SUBSTRATES FOR LIVE CELL APPLICATIONS | Promega Corporation (US) | 2016-12-07 | — | — | EP | disclosed |
| WO-2015116806-A1 | PRO-SUBSTRATES FOR LIVE CELL APPLICATIONS | PROMEGA CORPORATION (US) | 2015-08-06 | — | — | WO | disclosed |
| CN-103328597-A | Two-component curable composition | HENKEL AG & CO KGAA | 2013-09-25 | — | — | CN | disclosed |
| CN-102037039-B | Hardenable compositions based on silylated polyurethanes | HENKEL AG & CO KGAA | 2013-08-21 | — | — | CN | disclosed |
| US-8338499-B2 | Amine co-initiators for radiation curable compositions | AGFA GRAPHICS NV (BE) | 2012-12-25 | — | — | US | disclosed |
| US-8338499-B2 | Amine co-initiators for radiation curable compositions | AGFA GRAPHICS NV (BE) | 2012-12-25 | — | — | US | disclosed |
| US-8338499-B2 | Amine co-initiators for radiation curable compositions | AGFA GRAPHICS NV (BE) | 2012-12-25 | — | — | US | disclosed |
| EP-2121771-B1 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2012-06-27 | — | — | EP | disclosed |
| US-20100041784-A1 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2010-02-18 | — | — | US | disclosed |
| US-20100041784-A1 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2010-02-18 | — | — | US | disclosed |
| EP-1485377-B1 | PYRANONES USEFUL AS ATM INHIBITORS | KUDOS PHARM LTD (GB) | 2009-12-09 | — | — | EP | disclosed |
| EP-2121771-A1 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA Graphics NV (BE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008074758-A1 | NOVEL RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2008-06-26 | — | — | WO | disclosed |
| US-20070244133-A1 | Thienopyrimidines and Thiazolopyrimidines for Use in Medicine | ASTRAZENECA AB (SE) | 2007-10-18 | — | — | US | disclosed |
| US-20070244133-A1 | Thienopyrimidines and Thiazolopyrimidines for Use in Medicine | ASTRAZENECA AB (SE) | 2007-10-18 | — | — | US | disclosed |
| EP-0201164-B1 | POLYOLEFIN GRAFT POLYMERS AND LUBRICATING COMPOSITIONS CONTAINING THEM | TEXACO DEVELOPMENT CORPORATION (US) | 1992-09-30 | — | — | EP | disclosed |
| US-4640788-A | LUBRICANTS | TEXACO INC. (US) | 1987-02-03 | — | — | US | disclosed |
| EP-0201164-A2 | Polyolefin graft polymers and lubricating compositions containing them | TEXACO DEVELOPMENT CORPORATION (US) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244133-A1 | Thienopyrimidines and Thiazolopyrimidines for Use in Medicine | CXCR4, CXCR1, CXCR3 | PAOX 1036/4885HPGD 708/4885DUSP3 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.